Coronavirus 2019 Affliction Vaccine Response in Pregnant and Lactating Women

Ghulam Fiza  Nida Badar; Gulzar  Usman; Wali Muhammad  Nizamani; Fakhra  Ayyub; Shaheer  Ahmed; Jawaria  Ishfaq

doi:10.54393/pjhs.v3i05.237

Authors

Ghulam Fiza Nida Badar Shaikh Zaid Women's Hospital, Larkana, Pakistan
Gulzar Usman Department of Community Medicine, Liaquat University of Medical & Health Sciences (LUMHS), Sindh, Pakistan
Wali Muhammad Nizamani Department of Community Medicine, Liaquat University of Medical & Health Sciences (LUMHS), Sindh, Pakistan
Fakhra Ayyub Department of Family Medicine Zainab Clinic, Karachi, Pakistan
Shaheer Ahmed Dow Medical College DUHS, Karachi, Pakistan
Jawaria Ishfaq Nuclear Institute for Agriculture & Biology Collage-PIEAS, Faisalabad, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v3i05.237

Keywords:

COVID-19 vaccine, pregnancy, clinical trials, infection

Abstract

Vaccines have become more popular and influential in fighting against new viruses as the COVID-19 universal vaccine alongside the SARS-CoV-2 coronavirus began. Although high-quality approaches for blocking mortality exist, impoverished pregnant girls are included in composed tests. Cure safety should be taken into account when designing a mathematical, as well as when dealing with blast spheres and baby remnants. A concerted effort has been made to reassure pregnant women that there is a low risk of their child becoming infected with the flu. Given that COVID-19 has impacted people of all ages, a post-hoc dossier group should determine the effects of COVID-19 on future generations. Most people who receive COVID-19 injection responses experience injection-site erythema, discomfort, lump, fatigue, problem, fever, and lymphadenopathy. These symptoms can occur before or during birth. We have looked at some of the first-production fervid vector and mRNA COVID-19 vaccines known to cause adverse side effects, including backlashes in pregnant women and babies. We have looked at the potential implications of using the COVID-19 model to discover the enduring consequences of immunization against COVID-19 during the fetal and newborn ages

References

Dubé È, Dionne M, Rochette L. Exploring the impact of Quebec’s vaccine lottery and vaccine passports on Covid-19 vaccination intention: Findings from repeated cross-sectional surveys. Human Vaccines & Immunotherapeutics. 2022 Aug; 2100168.

Reuters WH. Warns Individuals against Mixing and Matching COVID Vaccines. Reuters. 2021 Jul.

Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Women's Health. 2021 Jun; 17:17455065211022262.

Karrow NA, Shandilya UK, Pelech S, Wagter-Lesperance L, McLeod D, Bridle B, et al. Maternal COVID-19 vaccination and its potential impact on fetal and neonatal development. Vaccines. 2021 Nov; 9(11):1351.

Maykin MM, Heuser C, Feltovich H. Pregnant people deserve the protection offered by SARS-CoV-2 vaccines. Vaccine. 2021 Jan;39(2):171.

Klein SL, Creisher PS, Burd I. COVID-19 vaccine testing in pregnant females is necessary. The Journal of clinical investigation. 2021 Mar; 131(5).

Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. British Medical Journal. 2020 Sep; 370:m3320. doi: 10.1136/bmj.m3320.

Marchand G, Patil AS, Masoud AT, Ware K, King A, et al. Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021. AJOG Global Reports. 2022 Feb; 2(1):100049. doi: 10.1016/j.xagr.2021.100049.

Metz TD, Clifton RG, Hughes BL, Sandoval GJ, Grobman WA, Saade GR, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Association of SARS-CoV-2 Infection with Serious Maternal Morbidity and Mortality from Obstetric Complications. Journal of the American Medical Association. 2022 Feb; 327(8):748-759. doi: 10.1001/jama.2022.1190.

Piekos SN, Roper RT, Hwang YM, Sorensen T, Price ND, Hood L, et al. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. The Lancet Digital Health. 2022 Feb;4(2): e95-104.

Stock SJ, Carruthers J, Calvert C, Denny C, Donaghy J, Goulding A, et al. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nature medicine. 2022 Mar; 28(3):504-12.

Strid P, Zapata LB, Tong VT, Zambrano LD, Woodworth KR, Riser AP, et al. COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status–United States, 2021 Jan.

Vousden N, Bunch K, Morris E, Simpson N, Gale C, O'Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: A national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One. 2021 May;16(5):e0251123. doi: 10.1371/journal.pone.0251123.

Edlow AG, Li JZ, Collier AY, Atyeo C, James KE, Boatin AA, et al. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic. JAMA Network Open. 2020 Dec; 3(12):e2030455. doi: 10.1001/jamanetworkopen.2020.30455.

Pique-Regi R, Romero R, Tarca AL, Luca F, Xu Y, Alazizi A, et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? elife. 2020 Jul; 9:e58716. doi: 10.7554/eLife.58716.

Ashary N, Bhide A, Chakraborty P, Colaco S, Mishra A, Chhabria K, et al. Single-Cell RNA-seq Identifies Cell Subsets in Human Placenta That Highly Expresses Factors Driving Pathogenesis of SARS-CoV-2. Frontiers in Cell and Developmental Biology. 2020 Aug; 8:783. doi: 10.3389/fcell.2020.00783.

Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, et al. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. New York state journal of medicine. 2021 May; 2(5):591-610.e10. doi: 10.1016/j.medj.2021.04.016.

Delorme-Axford E, Sadovsky Y, Coyne CB. The Placenta as a Barrier to Viral Infections. Annual review of virology. 2014 Nov; 1(1):133-46. doi: 10.1146/annurev-virology-031413-085524.

Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. British journal of obstetrics and gynaecology. 2020 Nov; 127(12):1548-1556. doi: 10.1111/1471-0528.16403.

Smithgall MC, Liu-Jarin X, Hamele-Bena D, Cimic A, Mourad M, Debelenko L, et al. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology. 2020 Dec; 77(6):994-999. doi: 10.1111/his.14215.

Garcia-Flores V, Romero R, Xu Y, Theis KR, Arenas-Hernandez M, Miller D, et al. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nature communications. 2022 Jan; 13(1):320. doi: 10.1038/s41467-021-27745-z.

Watkins JC, Torous VF, Roberts DJ. Defining Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Placentitis. Archives of Pathology & Laboratory Medicine. 2021 Nov; 145(11):1341-1349. doi: 10.5858/arpa.2021-0246-SA.

Linehan L, O'Donoghue K, Dineen S, White J, Higgins JR, Fitzgerald B. SARS-CoV-2 placentitis: An uncommon complication of maternal COVID-19. Placenta. 2021 Jan; 104:261-266. doi: 10.1016/j.placenta.2021.01.012.

Shook LL, Brigida S, Regan J, Flynn JP, Mohammadi A, Etemad B, et al. SARS-CoV-2 Placentitis Associated with B.1.617.2 (Delta) Variant and Fetal Distress or Demise. The Journal of infectious diseases. 2022 Mar; 225(5):754-758. doi: 10.1093/infdis/jiac008.

Fitzgerald B, O'Donoghue K, McEntagart N, Gillan JE, Kelehan P, et al. Fetal Deaths in Ireland Due to SARS-CoV-2 Placentitis Caused by SARS-CoV-2 Alpha. Archives of Pathology & Laboratory Medicine. 2022 May;146(5):529-537. doi: 10.5858/arpa.2021-0586-SA.

Schwartz DA, Avvad-Portari E, Babál P, Baldewijns M, Blomberg M, et al. Placental Tissue Destruction and Insufficiency From COVID-19 Causes Stillbirth and Neonatal Death From Hypoxic-Ischemic Injury. Archives of Pathology and Laboratory. 2022 Jun;146(6):660-676. doi: 10.5858/arpa.2022-0029-SA.

Kotlyar AM, Grechukhina O, Chen A, Popkhadze S, Grimshaw A, Tal O, et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology. 2021 Jan; 224(1):35-53.e3. doi: 10.1016/j.ajog.2020.07.049.

Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy—SET-NET, 16 jurisdictions, March 29–October 14, 2020. Morbidity and Mortality Weekly Report. 2020 Nov; 69(44):1635.

Flaherman VJ, Afshar Y, Boscardin WJ, Keller RL, et al. Infant Outcomes Following Maternal Infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): First Report From the Pregnancy Coronavirus Outcomes Registry (PRIORITY) Study. Archives of clinical infectious diseases. 2021 Nov; 73(9):e2810-e2813. doi: 10.1093/cid/ciaa1411.

Norman M, Navér L, Söderling J, Ahlberg M, Hervius Askling H, et al. Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes. Journal of the American Medical Association. 2021 May; 325(20):2076-2086. doi: 10.1001/jama.2021.5775.

Beharier O, Mayo RP, Raz T, Sacks KN, Schreiber L, Suissa-Cohen Y, et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. The Journal of clinical investigation. 2021 Jul;131(13).

Gee S, Chandiramani M, Seow J, Pollock E, Modestini C, Das A, et al. The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate. Nature immunology. 2021 Dec; 22(12):1490-1502. doi: 10.1038/s41590-021-01049-2.

Dahlgren J, Samuelsson AM, Jansson T, Holmäng A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatric research. 2006 Aug; 60(2):147-51. doi: 10.1203/01.pdr.0000230026.74139.18.

Mackin DW and Walker SP. The historical aspects of vaccination in pregnancy. Best Practice and Research in Clinical Obstetrics and Gynaecology. 2021 Oct; 76:13-22. doi: 10.1016/j.bpobgyn.2020.09.005.

Atyeo C, DeRiso EA, Davis C, Bordt EA, De Guzman RM, Shook LL, et al. COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women. Science translational medicine. 2021 Oct; 13(617):eabi8631. doi: 10.1126/scitranslmed. abi8631.

Ben-Mayor Bashi T, Amikam U, Ashwal E, Hershkovitz G, Attali E, Berkovitz-Shperling R, et al. The association of maternal SARS-CoV-2 vaccination-to-delivery interval and the levels of maternal and cord blood antibodies. International Journal of Gynecology & Obstetrics. 2022 Mar; 156(3):436-443. doi: 10.1002/ijgo.14014.

Freitas DA, Souza-Santos R, Carvalho LMA, Barros WB, Neves LM, Brasil P, et al. Congenital Zika syndrome: A systematic review. PLoS One. 2020 Dec;15(12):e0242367. doi: 10.1371/journal.pone.0242367.

Lamont RF, Sobel JD, Carrington D, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, et al.

Varicella-zoster virus (chickenpox) infection in pregnancy. British journal of obstetrics and gynaecology. 2011 Sep; 118(10):1155-62. doi: 10.1111/j.1471-0528.2011.02983. x.

Kachikis A, Englund JA, Singleton M, Covelli I, Drake AL, Eckert LO. Short-term Reactions Among Pregnant and Lactating Individuals in the First Wave of the COVID-19 Vaccine Rollout. JAMA Network Open. 2021 Aug; 4(8):e2121310. doi: 10.1001/jamanetworkopen.2021.21310.

Maertens K, Orije MRP, Van Damme P, Leuridan E. Vaccination during pregnancy: current and possible future recommendations. European journal of pediatrics. 2020 Feb; 179(2):235-242. doi: 10.1007/s00431-019-03563-w.

Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, et al. COVID-19 vaccination during pregnancy: coverage and safety. American Journal of Obstetrics and Gynecology. 2022 Feb; 226(2): 236.e1-236.e14. doi: 10.1016/j.ajog.2021.08.007.

Dick A, Rosenbloom JI, Karavani G, Gutman-Ido E, Lessans N, Chill HH. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy. American Journal of Obstetrics and Gynecology. 2022 Jul; 4(4):100637. doi: 10.1016/j.ajogmf.2022.100637.

Ontario BO. COVID-19 vaccination during pregnancy in Ontario. BORN Ontario https://www. bornontario. ca/en/whats-happening/covid-19-vaccination-during-pregnancy-in-ontario. aspx. 2021 Dec.

Zauche LH, Wallace B, Smoots AN, Olson CK, Oduyebo T, Kim SY, et al. CDC v-safe Covid-19 Pregnancy Registry Team. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. The New England journal of medicine. 2021 Oct; 385(16):1533-1535. doi: 10.1056/NEJMc2113891.

Kharbanda EO, Haapala J, DeSilva M, Vazquez-Benitez G, Vesco KK, et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. Journal of the American Medical Association. 2021 Oct; 326(16):1629-1631. doi: 10.1001/jama.2021.15494.

Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Håberg SE. Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage. The New England journal of medicine. 2021 Nov; 385(21):2008-2010. doi: 10.1056/NEJMc2114466.

Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, et al. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021. Morbidity and Mortality Weekly Report (MMWR). 2022 Jan; 71(1):26-30. doi: 10.15585/mmwr.mm7101e1.

Goldshtein I, Steinberg DM, Kuint J, Chodick G, Segal Y, Shapiro Ben David S, et al. Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes. JAMA Pediatrics. 2022 May; 176(5):470-477. doi: 10.1001/jamapediatrics.2022.0001.

Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, et al. Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. Journal of the American Medical Association. 2021 Aug; 326(8):728-735. doi: 10.1001/jama.2021.11035

Buyon JP. The effects of pregnancy on autoimmune diseases. Journal of leukocyte biology. 1998 Mar; 63(3):281-7. doi: 10.1002/jlb.63.3.281.

Atyeo CG, Shook LL, Brigida S, De Guzman RM, Demidkin S, Muir C, et al. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms. Nature communications. 2022 Jun;13(1):1-5.

Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nature Medicine. 2021 Oct; 27(10):1693-1695. doi: 10.1038/s41591-021-01490-8.

Vousden N, Ramakrishnan R, Bunch K, Morris E, Simpson N, Gale C, et al. Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: Data from the UK Obstetric Surveillance System national cohort. medRxiv. 2021. doi.org/10.1101/2021.07.22.21261000